The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series D | Alive

Total Raised


Last Raised

$8.1M | 13 yrs ago

About Chase Medical

Chase Medical is developing medical technology for treating congestive heart failure. Chase Medical is developing a device called the Mannequin which aims to help the heart maintain its shape while going through reconstruction of the left ventricle.

Chase Medical Headquarter Location

1876 Firman Drive

Richardson, Texas, 75081,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Chase Medical Patents

Chase Medical has filed 6 patents.

patents chart

Application Date

Grant Date


Related Topics




Health informatics, Electronic health records, Telehealth, Pseudoscience, Health standards


Application Date


Grant Date



Related Topics

Health informatics, Electronic health records, Telehealth, Pseudoscience, Health standards



Chase Medical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Chase Medical Rank

  • When was Chase Medical founded?

    Chase Medical was founded in 1995.

  • Where is Chase Medical's headquarters?

    Chase Medical's headquarters is located at 1876 Firman Drive, Richardson.

  • What is Chase Medical's latest funding round?

    Chase Medical's latest funding round is Series D.

  • How much did Chase Medical raise?

    Chase Medical raised a total of $17.1M.

  • Who are the investors of Chase Medical?

    Investors of Chase Medical include Capital Southwest, First Capital Group and Red River Ventures.

  • Who are Chase Medical's competitors?

    Competitors of Chase Medical include Respicardia, Cayenne Medical, CardioKinetix, CircuLite, MiCardia and 13 more.

You May Also Like


CardioKinetix develops a percutaneous treatment for patients with left ventricular dilation after an anterior myocardial infarction (MI). The implantable device, called the PARACHUTE is a partitioning membrane deployed within the compromised ventricle. The PARACHUTE partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, and decreases the overall volume. Options for patients whose ventricle has enlarged are limited, with most on medical therapy and/or a cardiac resynchronization device that only benefits heart failure patients with a specific EKG pattern.

Cardiac Power

Cardiac Power is a non-blood-contacting left ventricular assist device for the treatment of congestive heart failure


CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.

Bio Control Medical

Bio Control Medical offers implantable devices for the treatment of incontinence and congestive heart failure.


Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of congestive heart failure.

Ancora Heart Logo
Ancora Heart

Ancora Heart is developing a therapy to address heart failure. Ancora Heart's AccuCinch Ventricular Repair System is a minimally invasive investigational treatment for heart failure and functional mitral regurgitation (FMR).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.